Clinical Trial

The Utility of Thromboelastography in Traumatic Brain Injury

Recruiting
View on ClinicalTrials.gov →
Summary
Hemocoagulation disorder is recognized to have crucial effects on hemorrhagic or ischemic diseases. Coagulation-related damages secondary to traumatic brain injury are common and severe secondary insults of head trauma and often leads to a poor prognosis. In this study, we sought to assess if posttraumatic hemocoagulation disorders determined using thromboelastography are associated with coagulation-related damages secondary to traumatic brain injury, and evaluate their influence on outcome among patients with head trauma. Based on above results, prediction models or risk scoring systems will be further developed and validated to predict coagulation-related damages secondary to traumatic brain injury.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-08-20; most recent amendment 2025-03-13.
Trial Details
NCT Number NCT04524637
Lead Sponsor Shanghai 6th People's Hospital
Conditions Traumatic Brain Injury, Coagulation Disorder
Enrollment 500 participants
Start Date 2018-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-17